Jupiter Neurosciences (JUNS) director reports no share holdings

Rhea-AI Filing Summary

Jupiter Neurosciences, Inc. filed an initial Form 3 for Andrew Jon Cutler, identifying him as a director of the company. The filing shows no reported equity holdings, derivative positions, purchases, or sales. Remarks reference an Exhibit 24 Power of Attorney related to future SEC reporting.

Key Terms

Power of Attorney, Exhibit 24

2 terms

Power of Attorney regulatory

"Exhibit List - Exhibit 24 - Power of Attorney"

A power of attorney is a legal document that allows one person to make decisions and act on behalf of another person, often in financial or legal matters. It’s like giving someone a trusted helper or agent the authority to handle important tasks if you are unable to do so yourself. This matters to investors because it can impact how their assets are managed or transferred if they become unable to oversee their affairs.

Exhibit 24 regulatory

"Exhibit List - Exhibit 24 - Power of Attorney"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Understanding Insider Trading Forms →

Available on EDGAR 07/22/2026 - 09:13 PM Accepted by SEC EDGAR 07/22/2026 - 09:12 PM Learn about SEC filing dates

FAQ

What does the JUNS Form 3 for Andrew Jon Cutler disclose?

The Form 3 for Jupiter Neurosciences (JUNS) identifies Andrew Jon Cutler as a director and provides his initial insider ownership disclosure. It reports no beneficially owned JUNS securities, no derivative positions, and no insider transactions as of this filing.

Does Andrew Jon Cutler report owning any JUNS shares on this Form 3?

No, this Form 3 does not list any Jupiter Neurosciences (JUNS) securities as beneficially owned by Andrew Jon Cutler. The structured data show zero holdings entries and no transactions, indicating no positions are reported in this submission.

Are there any insider buy or sell transactions for JUNS in this Form 3?

No, the Form 3 for Jupiter Neurosciences (JUNS) reports no buy or sell transactions. Transaction counts for purchases, sales, exercises, gifts, or restructurings are all zero, so only insider status is being reported, not trading activity.

What is Andrew Jon Cutler’s role at Jupiter Neurosciences (JUNS)?

According to the Form 3, Andrew Jon Cutler is a director of Jupiter Neurosciences (JUNS). He is not reported as an officer or 10% owner in this filing, so his insider status arises from his board membership.

What does the Power of Attorney reference mean in the JUNS Form 3?

The remarks reference an Exhibit 24 Power of Attorney, authorizing designated persons to sign SEC documents on Andrew Jon Cutler’s behalf. This is an administrative arrangement for handling future filings and does not itself involve any securities transactions.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Cutler Andrew Jon

(Last) (First) (Middle)

C/O JUPITER NEUROSCIENCES, INC.

1001 NORTH US HWY 1, SUITE 504

(Street)

JUPITER FLORIDA 33477

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
07/22/2026

3. Issuer Name and Ticker or Trading Symbol
JUPITER NEUROSCIENCES, INC. [ JUNS ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney

No securities are beneficially owned.

	/s/ Andrew J. Cutler	07/22/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)